HOLLISTON, Mass.--(BUSINESS WIRE)--Harvard Apparatus Regenerative Technology, Inc. (NASDAQ: HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, will announce results of its first quarter ended March 31, 2015 before market trading hours on Thursday, May 7, 2015. A conference call to discuss the company’s first quarter results is scheduled for that same day at 11:00 AM (Eastern Time). On that call, management may respond to questions from the audience on any of a number of topics related to the business, including clinical and preclinical research, operations, plans and outlook.
Help employers find you! Check out all the jobs and post your resume.
